Study in Parkinson's Disease Patients With Dyskinesia With Combinations of JM-010 and Its Individual Components
Clinical trial NCT04377945 · TERMINATED
Trial details
- NCT number
- NCT04377945
- Sponsor
- Bukwang Pharmaceutical
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-28
- Primary completion
- 2024-02-14
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.